- Investing | January 27, 2016
3 Reasons Illumina Inc. Stock Could Fall
This genomic sequencing leader appears to be suffering from multiple revenue headwinds -- at least in the near term.
- Investing | January 24, 2016
Will 2016 Be Illumina Inc.'s Best Year Yet?
Here's what it will take for this genomic sequencing company to succeed in 2016.
- Investing | January 11, 2016
Why Pacific Biosciences of California Inc Is Down Big Today
A slower than hoped for launch of the company's new Sequel System is pressuring shares on Monday.
- Investing | January 06, 2016
Why Pacific Biosciences of California Shares Jumped 68% in 2015
The introduction of a new and cheaper gene sequencing model could give this company an edge.
- Investing | December 18, 2015
Pacific Biosciences of California's Stock Move Is Certifiable
A double-digit jump on no news.
- Investing | November 19, 2015
Why Pacific Biosciences of California Is Soaring Higher Today
Investors continue to grow bullish on the company's near term prospects, sending shares to a fresh 52-week high.
- Investing | November 12, 2015
Why Pacific Biosciences of California Jumped 30% in October
The launch of a new sequencing platform gives investors a strong reason to cheer.
- Investing | November 07, 2015
Genomic Health, Inc. on Path to Profitability
Strong growth in tests combined with an increase in reimbursement.
- Investing | November 01, 2015
Qiagen NV Earnings: Just What You'd Expect
Nothing special here, but nothing bad, either. Look forward to 2016.
- Investing | October 27, 2015
Why Pacific Biosciences of California Went Up, Then Down, Then Sideways
It can be hard to value a company at its inflection point.